SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
La Jolla Institute Gets $1M Gift for COVID Research
La Jolla Institute for Immunology received a $1 million gift to further its work in COVID-19 research. The GHR Foundation, an independent philanthropy based in Minneapolis, made the gift, announced on Aug. 4.
BioAtla Raises $72.5M Series D Round Led By Soleus Capital
BIOTECH: Co. Has Two Drugs In Clinical Trials With Plans to Expand
Phamatech Signs Deal with Broward County School
Phamatech will provide on-site sample collection at six school district locations that will then be sent to Phamatech’s laboratory in San Diego for analysis.
Arcturus Therapeutics Makes Case for Experimental RNA-Based COVID-19 Vaccine
BIOTECH: Receives Greenlight on Phase 1/2 of Clinical Trials
Truvian Gains EUA Approval From FDA
Truvian Sciences has received federal emergency approval for its COVID-19 antibodies.
Arcturus Moves Forward With COVID-19 Vaccine Clinical Trial
San Diego-based Arcturus Therapeutics Inc. announced its vaccine has been approved to proceed with Phase 1/2 Clinical Trial
Transplant Games Slated for Summer 2022
San Diego will host the Donate Life Transplant Games 24 months from now. The San Diego County Credit Union Holiday Bowl organization led the successful bid to bring the games to San Diego.
Industry Veterans Start New Company, Raise $78M For Cell-Based Cancer Therapies
BIOTECH: Artiva Biotherapeutics to Start Clinical Trials This Year
Illumina Software Buy Estimated At $100 Million
GENOMICS: Deal Seen as Widening Competitive Edge
Hotels, Salons, Hospitals Turn to Powerful Light to Disinfect and Sanitize
SAFETY: Local Companies Find New Ways to Fight COVID-19
Acadia Submits New Drug Application to FDA
Acadia Pharmaceuticals has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration.
Artiva Biotherapeutics Launches with $78M Series A Financing
Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies
Carlsmed Raises $2.5M to Improve Spine Surgery
Carlsmed, Inc., a San Diego-based MedTech company, has closed an oversubscribed $2.5 million seed round.
Nanome Helps Scientists Tackle Virus from Multiple Angles
Startup Provides Software to Over 250 Universities and Top Pharmaceutical Corporations
I-15 Corridor a Thriving Market For Commercial Real Estate
PROPERTY: Demand So Strong Some Developers Moving Ahead on Spec Projects
Prev Next